Not Yet Recruiting
A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia
NCT07692529
- Conditions
- Evaluation of the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (T-LGLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified